
Singapore Medical Group Limited is placing 25.6m shares (comprising 8.55m new shares and 17.05m vendor shares) at 21 cents each for a listing on Catalist. Once again, Primepartners have teamed up with DMG to launch this issue. Prime has also helped list its peers Healthway back in June 2008.
The Company is a healthcare industry and provides specialist healthcare services. It is established in the fields of LASIK procedures and sports medicine. Revenue has grown from $4.3m in FY2006 to $30.1m in FY2008 but net profit has been more "volatile", increasing from $1.3m in FY2006 to $8.1m in FY2007 before dropping to $5.0m in FY 2008. The offer will close on 21 July 2009 but is via placement only. The market cap post IPO will be $30.6m. EPS based on the enlarged share cap and FY2008 net profit assuming the Service Agreements have been effected will be Singapore 2.87 cents and that will translate into a PE of 7.3x historical.
There are not much IPO proceeds to talk of, the majority of the amount raised will be paid to the owners of the company and after deducting the IPO expenses of $1.063m, there will only be $0.7m. I feel that the IPO expenses should be borne on a "pro-rata"basis since the majority of the proceeds raised is going to the vendors. The company intends to pay an interim and final dividend approximately 20% of the consolidated net profits attributable to shareholders for FY2009 and FY2010. After the IPO. the public will hold 17.6% shares and is likely to be thinly traded. It is interesting to note that 3 directors will be paid more than $250,000 per annum for FY 2009 while only 1 received such remuneration previously in FY 2008. The company also has a few family members working in the firm but their pay will be reviewed annually to ensure it is "fair".....hmmm..
Anyway, while i like the way which the company is being positioned (to earn money from the "ai swee" people who goes for asthetic surgery), i think the company is fairly valued at its IPO price. However, it is trading at more attractive valuations then Healthway.
The Company is a healthcare industry and provides specialist healthcare services. It is established in the fields of LASIK procedures and sports medicine. Revenue has grown from $4.3m in FY2006 to $30.1m in FY2008 but net profit has been more "volatile", increasing from $1.3m in FY2006 to $8.1m in FY2007 before dropping to $5.0m in FY 2008. The offer will close on 21 July 2009 but is via placement only. The market cap post IPO will be $30.6m. EPS based on the enlarged share cap and FY2008 net profit assuming the Service Agreements have been effected will be Singapore 2.87 cents and that will translate into a PE of 7.3x historical.
There are not much IPO proceeds to talk of, the majority of the amount raised will be paid to the owners of the company and after deducting the IPO expenses of $1.063m, there will only be $0.7m. I feel that the IPO expenses should be borne on a "pro-rata"basis since the majority of the proceeds raised is going to the vendors. The company intends to pay an interim and final dividend approximately 20% of the consolidated net profits attributable to shareholders for FY2009 and FY2010. After the IPO. the public will hold 17.6% shares and is likely to be thinly traded. It is interesting to note that 3 directors will be paid more than $250,000 per annum for FY 2009 while only 1 received such remuneration previously in FY 2008. The company also has a few family members working in the firm but their pay will be reviewed annually to ensure it is "fair".....hmmm..
Anyway, while i like the way which the company is being positioned (to earn money from the "ai swee" people who goes for asthetic surgery), i think the company is fairly valued at its IPO price. However, it is trading at more attractive valuations then Healthway.
